Extra-intestinal Applications of Fecal Microbiota Transplantation, Volume Two: Future Directions and Applications in Neuropsychiatric, Infectious, and Cardiovascular Diseases provides real world applications of Fecal Microbiota Transplantation (FMT) in various neuropsychiatric, infectious, and cardiovascular pathologies. The content provides a comprehensive view of FMT beyond intestinal pathologies, including content on extra-intestinal applications of FMT and lesser-known concepts of gut brain axis and the heart gut axis. Content coverage also includes a comparison of regulatory guidelines for FMT in various countries and various routes of administration of FMT with advantages and limitations. This is the perfect reference for researchers involved in work on bacteriotherapeutics as it provides a comprehensive view of the extra-intestinal applications of FMT while discussing the lesser known concepts of the gut axis.
Table of Contents
Application of FMT in neuropsychiatric diseases 1. FMT in Parkinson's disease 2. FMT in Alzheimer's disease 3. FMT in multiple sclerosis (MS) 4. FMT in epilepsy 5. FMT in Tourette Syndrome (TS) 6. FMT in chronic fatigue syndrome (CFS) 7. FMT in Guillain-Barr� syndrome (GBS) 8. FMT in stroke 9. FMT in autism spectrum disorder 10. FMT in depression and anxiety 11. FMT in bipolar disorder, schizophrenia 12. FMT in addiction 13. FMT in vaginosis Application of FMT in cardiovascular diseases 14. FMT in hypertension 15. FMT in cardiac failure Conclusive information 16. FMT-Safety and regulation 17. Future directions
Authors
Monica Gulati Registrar and Sr. Dean at the School of Pharmaceutical Sciences, Lovely Professional University, India. Dr Monica Gulati is the Registrar and Sr. Dean at the School of Pharmaceutical Sciences, Lovely Professional University with more than 25 years of teaching, industry, research and administrative experience. Her research forte is enhancing bio-performance of drug molecules including small and large biomolecules, phytochemicals and probiotics, metabiotics and other biotherapeutics using conventional and novel dosage forms especially in the area of colon targeting. She holds a keen interest in the quality control parameters of delivery systems. Her group has designed novel platform technologies to overcome challenges in therapeutic delivery of different classes of phyto-polypeptides and phytochemicals. She has more than 125 high impact publications and 15 invited book chapters to her credit, with an H-index of 26 and RG score of 38.3. She has been granted two Indian patents and three Australian patents while eighteen more have been filed and published. She is on the Editorial and Review Board of more than 25 journals. Sachin Kumar SinghDr. Sachin Kumar Singh, is working as professor and head of Pharmaceutical Chemistry and Pharmaceutical Analysis at School of Pharmaceutical Sciences, Lovely Professional University, India and visiting professor Australian Research Centre in Complementary and Integrative Medicine (ARCCIM), School of Public Health, Faculty of Health, University of Technology Sydney, Australia. He has many years of teaching and research experience. Dr. Singh has published more than 350 research papers with cumulative impact of 1300, authored several books, and dozens of book chapters. He is also featured under top 2% scientists of world as per the list of 2021, published by Stanford University, USA.
Bhupinder Kapoor Associate Professor, School of Pharmaceutical Sciences, Lovely Professional University, India. Dr. Bhupinder Kapoor is presently working as Associate Professor at School of Pharmaceutical Sciences, Lovely Professional University, India. Dr. Kapoor earned his doctoral degree in Pharmaceutical Sciences from Lovely Professional University, Punjab, India. With an expertise in the physic-chemical and physic-mechanical properties of vesicular and complex delivery systems, he has authored more than 40 international publications in well reputed peer-reviewed journals including book chapters. He is on the rewire board of a number of high impact journals. His current research focuses on drug delivery and targeting, nanomedicine, and nutraceuticals.
